The Annual Report for 2025 is attached to this press release and can also be downloaded at www.gradientech.se
For further information, please contact:
Sara Thorslund, PhD, CEO
Tel: +46 736 29 35 80
[email protected]
Urban Adolfsson, CFO
Tel: + 46 708 20 72 09
[email protected]
About Gradientech
Gradientech is a leader in ultra-rapid antibiotic susceptibility testing, developing next-generation diagnostics for infectious disease medicine. Our innovative diagnostic solutions aim to save lives, reduce healthcare costs, and combat the spread of antibiotic resistance - one of our greatest global health threats. Gradientech is headquartered in Uppsala, Sweden. Visit gradientech.se for more information.